Imed Pharmaceuticals (India) Private Limited - Company Profile

It is a healthcare private limited company based in Hubli, Karnataka, India, established in 2008.
2008 Hubli, Karnataka, India Active
Last Updated:
Access Report
About Imed Pharmaceuticals (India) Private Limited

Imed Pharmaceuticals (India) Private Limited, a active private limited company, was established on 15 July 2008 in Hubli, Karnataka, India. Engaging in preventive health services within the trade sector, it holds CIN: U24200KA2008PTC047159. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹8.99 M.

It upholds a active non-compliant status. Its leadership includes Narasappa Swamy Bhavikatti (Director), Gayathri Bhavikatti (Director). Past directors included Sanjay Kukreja Cheturam, Deepak Arjundas Kukreja. It holds ₹8.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at Lg-2, Akshaya Complex, Bailappanavar Nagar,, Hubli, Karnataka, 580029.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200KA2008PTC047159

  • Registration Number

    047159

  • Incorporation Date

    15 July 2008

  • Authorized Capital

    ₹2.50 Cr

  • Paid-Up Capital

    ₹8.99 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 8.99 M
  • Company Age 17 Year, 8 Months
  • Last Filing with ROC 31 Mar 2015
  • Open Charges ₹ 8.75 Cr
  • Revenue Growth **** -30.18%
  • Profit Growth **** -141584.03%
  • Ebitda **** -588.60%
  • Net Worth -500.07%
  • Total Assets -65.06%
Company report

Imed Pharmaceuticals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Imed Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Imed Pharmaceuticals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Narasappa Swamy Bhavikatti Director 15 Jul 2008 Current
Gayathri Bhavikatti Director 15 Jul 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2015 Past
Pramod Abcsdd Director 31 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Imed Pharmaceuticals (India).

Imed Pharmaceuticals (India) Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 30.18% decrease. The company also saw a substantial fall in profitability, with a 141584.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 500.07%.

Imed Pharmaceuticals (India) revenue growth over time
Imed Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -30.18%
*******
*******
*******
*******
Revenue from Operations
*******
 -75.95%
*******
*******
*******
*******
Total Assets
*******
 -65.06%
*******
*******
*******
*******
Profit or Loss
*******
 -141584.03%
*******
*******
*******
*******
Net Worth
*******
 -500.07%
*******
*******
*******
*******
EBITDA
*******
 -588.60%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Imed Pharmaceuticals (India)?

In 2015, Imed Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹87,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Krishnakumar G. Agrawal On Behalf Of Kare Labs Private Limited : 5.00 Cr
  • Axis Bank Limited : 3.75 Cr
Latest Charge Details
Date Lender Amount Status
20 Dec 2012 Axis Bank Limited ₹3.75 Cr Open
21 Aug 2012 Krishnakumar G. Agrawal On Behalf Of Kare Labs Private Limited ₹5.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Imed Pharmaceuticals (India)?

Imed Pharmaceuticals (India) has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Imed Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imed Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Imed Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Imed Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Imed Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Bangalore. was documented.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 3.75 Cr with Charge ID 10394589 was registered on 20 Dec 2012. was recorded as a recent event.

  • Charges

    The activity A charge with Krishnakumar G. Agrawal On Behalf Of Kare Labs Private Limited amounted to Rs. 5.00 Cr with Charge ID 10380225 was registered on 21 Aug 2012. was completed.

  • Director Appointment

    Narasappa Swamy Bhavikatti was appointed as a Director was appointed as a Director on 15 Jul 2008 & has been associated with this company since 17 years 8 months . was recorded as a recent event.

  • Director Appointment

    Gayathri Bhavikatti was appointed as a Director was appointed as a Director on 15 Jul 2008 & has been associated with this company since 17 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Imed Pharmaceuticals (India) Private Limited?

The CIN of Imed Pharmaceuticals (India) Private Limited is U24200KA2008PTC047159.

Where is Imed Pharmaceuticals (India) Private Limited headquartered?

Imed Pharmaceuticals (India) Private Limited is headquartered at Lg-2, Akshaya Complex, Bailappanavar Nagar,, Hubli, Karnataka, 580029.

When was Imed Pharmaceuticals (India) Private Limited incorporated?

Imed Pharmaceuticals (India) Private Limited was incorporated on 15 July 2008.

Who are the current directors of Imed Pharmaceuticals (India) Private Limited?

The current directors of Imed Pharmaceuticals (India) Private Limited are

What is the primary industry of Imed Pharmaceuticals (India) Private Limited?

The primary industry of Imed Pharmaceuticals (India) Private Limited is Trade.

Is Imed Pharmaceuticals (India) Private Limited a listed company?

Imed Pharmaceuticals (India) Private Limited is unlisted.

What is the capital structure of Imed Pharmaceuticals (India) Private Limited?

The authorized capital of Imed Pharmaceuticals (India) Private Limited is ₹2.50 Cr, and the paid-up capital is ₹8.99 M.

What is the compliance status of Imed Pharmaceuticals (India) Private Limited?

The compliance status of Imed Pharmaceuticals (India) Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available